PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 6, 2026RSC Advances0 citationsOpen Access

Synergistic NIR-polydopamine nanotherapy for blood–brain barrier crossing and Parkinson's disease intervention

View Full Paper
XXXueer XiaJHJennie HanMLMeiyin Lin

Key Points

  • The research aims to explore a new approach for treating Parkinson's disease by utilizing a novel nanotherapy that can cross the blood–brain barrier.
  • Synthesis of ZnO@PDA as a nanotherapy platform.
  • Utilization of photothermal effects to aid blood–brain barrier crossing.
  • Application of ultrasound to trigger neuronal stimulation.
  • Implementation of antioxidant therapy.
  • Successful synthesis of ZnO@PDA for targeted therapy.
  • Effective opening of the blood–brain barrier using photothermal methods.
  • Induction of neuronal stimulation through ultrasound.
  • Enhanced antioxidant defense mechanisms in neuronal cells.

Abstract

This study synthesizes ZnO@PDA as a non-invasive platform for Parkinson's disease treatment. They utilize photothermal effects to open the blood–brain barrier, enable ultrasound-triggered neuronal stimulation, and provide antioxidant therapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Xia et al. (2026) studied this question.

synapsesocial.com/papers/698585aa8f7c464f23009276https://doi.org/10.1039/d5ra07719b
Ask AI
Helpful
Bookmark
Share
View Full Paper